Malignt melanom – Hildur Helgadottirs forskargrupp

Publikationer

Utvalda publikationer

• Article: ACTA ONCOLOGICA. 2023;62(12):1921-1930

  Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and tolerability.

  Backlund E; Grozman V; Egyhazi Brage S; Lewensohn R; Lindberg K; Helgadottir H
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023;115(9):1077-1084

  Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study.

  Helgadottir H; Ny L; Ullenhag GJ; Falkenius J; Mikiver R; Olofsson Bagge R; Isaksson K
• Letter: ACTA ONCOLOGICA. 2022;61(9):1116-1120

  Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy.

  Costa Svedman F; Jalsenius M; Grozman V; Bergqvist M; Söderdahl F; Rotstein S; Ny L; Egyhazi Brage S; Helgadottir H
• Article: CANCERS. 2022;14(15):3587

  Proliferation and Immune Response Gene Signatures Associated with Clinical Outcome to Immunotherapy and Targeted Therapy in Metastatic Cutaneous Malignant Melanoma.

  Costa Svedman F; Das I; Tuominen R; Darai Ramqvist E; Höiom V; Egyhazi Brage S
• Letter: ACTA ONCOLOGICA. 2022;61(7):869-873

  Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial.

  Backlund E; Yang M; Grozman V; Masucci G; Falkenius J; Eriksson H; Jovanovic B; Hammarlund K; Isacsson U; Radu C; Abel E; Karlsson K; Palanco Zamora R; Wersäll P; Edbäck U; Wickström S; Darai Ramqvist E; Egyhazi Brage S; Kiessling R; Viktorsson K; Franzén B; Lewensohn R; Olofsson Bagge R; Ullenhag GJ; Ny L; Lindberg K; Helgadottir H
• Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(3 Pt A):736-740.e6

  Coexpression of MTH1 and PMS2 Is Associated with Advanced Disease and Disease Progression after Therapy in Melanoma.

  Das I; Tuominen R; Helleday T; Hansson J; Warpman Berglund U; Egyházi Brage S
• Article: GENETICS IN MEDICINE. 2022;24(1):157-169

  Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.

  Yang M; Johnsson P; Bräutigam L; Yang XR; Thrane K; Gao J; Tobin NP; Zhou Y; Yu R; Nagy N; Engström PG; Tuominen R; Eriksson H; Lundeberg J; Tucker MA; Goldstein AM; Egyhazi-Brage S; Zhao J; Cao Y; Höiom V
• Article: CANCER RESEARCH. 2021;81(9):2545-2555

  Inflammation and Apolipoproteins Are Potential Biomarkers for Stratification of Cutaneous Melanoma Patients for Immunotherapy and Targeted Therapy.

  Karlsson MJ; Costa Svedman F; Tebani A; Kotol D; Höiom V; Fagerberg L; Edfors F; Uhlén M; Egyhazi Brage S; Maddalo G
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2021;113(3):318-328

  Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.

  Helgadottir H; Isaksson K; Fritz I; Ingvar C; Lapins J; Höiom V; Newton-Bishop J; Olsson H
• Article: JOURNAL OF MEDICAL GENETICS. 2020;57(5):316-321

  Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations.

  Helgadottir H; Ghiorzo P; van Doorn R; Puig S; Levin M; Kefford R; Lauss M; Queirolo P; Pastorino L; Kapiteijn E; Potrony M; Carrera C; Olsson H; Höiom V; Jönsson G
• Article: CELL DEATH & DISEASE. 2019;10(9):663

  Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status.

  Das I; Wilhelm M; Höiom V; Franco Marquez R; Costa Svedman F; Hansson J; Tuominen R; Egyhàzi Brage S
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2016;108(11):djw135

  Germline CDKN2A Mutation Status and Survival in Familial Melanoma Cases.

  Helgadottir H; Höiom V; Tuominen R; Nielsen K; Jönsson G; Olsson H; Hansson J

Medlemmar och kontakt

Gruppledare

• 

  Hildur Helgadottir

  Senior Forskningsspecialist | Docent

  E-postadress hildur.helgadottir@ki.se

Alla medlemmar i gruppen

• 

  Suzanne Egyhazi Brage

  Senior Forskningsspecialist

  E-postadress suzanne.egyhazi.brage@ki.se
• Johan Falkenius

  Anknuten till Forskning

  E-postadress johan.falkenius@ki.se
• 

  Hildur Helgadottir

  Senior Forskningsspecialist | Docent

  E-postadress hildur.helgadottir@ki.se
• Ellen Heurlin

  Doktorand

  E-postadress ellen.heurlin@ki.se
• 

  Veronica Höiom

  Senior Forskningsspecialist

  E-postadress veronica.hoiom@ki.se
• 

  Karin Kjulin

  Annan Grund

  Telefon +46852481208

  E-postadress karin.kjulin@ki.se
• Cissi Liu

  Doktorand

  E-postadress cissi.liu@ki.se
• Francesca Portelli

  Doktorand

  E-postadress francesca.portelli@ki.se
• Karina Schultz

  Doktorand

  E-postadress karina.schultz@ki.se
• Muyi Yang

  Postdoktor

  E-postadress muyi.yang@ki.se